Stock A068270CELLTRION, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Celltrion, Inc.

Equities

A068270

KR7068270008

Biotechnology & Medical Research

End-of-day quote Korea S.E.
Other stock markets
 2025-03-21 		5-day change 1st Jan Change
186,700.00 KRW +0.21% Intraday chart for Celltrion, Inc. +0.32% -0.43%
Mar. 20 Celltrion Inc To Acquire 50 Billion Won Worth Of Its Own Shares RE
Mar. 20 Celltrion, Inc. announces an Equity Buyback for 268,385 shares. CI

Chart calendar Celltrion, Inc.

e025a4fd12f3854d.D7dFOx-9rX8tPlXpwJQD5SDDpV5VLPgWV3VcYzkyQsc.OPoneECKnDoYTBLfkPJcqmX6lm0xVrRyIzsVIHhcb_Jk4i50XPH3CFQNGA~b890b91eb26e37522375f9501be2011e

Upcoming events on Celltrion, Inc.

2025-05-07 Q1 2025 Earnings Release (Projected)
2025-08-07 Q2 2025 Earnings Release (Projected)
2025-11-05 Q3 2025 Earnings Release (Projected)
2026-05-06 Q1 2026 Earnings Release (Projected)

Past events on Celltrion, Inc.

2025-02-24 Q4 2024 Earnings Release
2024-11-27 02:00 am Investor Meeting
2024-11-07 Q3 2024 Earnings Release
2024-08-13 Q2 2024 Earnings Release
2024-05-08 Q1 2024 Earnings Release
2024-02-28 Q4 2023 Earnings Release
2024-01-09 JPMorgan Healthcare Conference
2023-11-06 Q3 2023 Earnings Release
2023-09-12 Roadshow - Day - 2
2023-09-11 Roadshow - Day - 1
2023-09-11 03:35 pm Morgan Stanley Global Healthcare Conference - Fireside Chat
2023-08-24 03:00 am Investor Meeting
2023-08-17 03:30 am Investor Meeting
2023-05-07 Q1 2023 Earnings Release
2023-03-19 Q4 2022 Earnings Release
2022-11-13 Q3 2022 Earnings Release
2022-08-15 Interim 2022 Earnings Release
2022-05-15 Q1 2022 Earnings Release
2022-02-15 FY 2021 Earnings Release
2021-11-09 Q3 2021 Earnings Release

Past dividends on Celltrion, Inc.

2024-12-26 Annual 750 KRW
2023-12-26 Annual 500 KRW
2022-12-27 Annual 375 KRW
2021-12-28 Annual 750 KRW
2012-12-26 Annual 15 KRW
2011-12-27 Annual 100 KRW
2010-12-28 Annual 75 KRW
2007-12-26 Annual 50 KRW

Annual results

Fiscal PeriodDecember 2022 2023 2024 2025 2026 2027
Net sales
Billions KRW		Released
Forecast
Spread 		2 284
2 367
-3.53%		2 176
2 369
-8.11%		3 557
3 498
1.68%
4 531


5 371


6 370

EBITDA
Billions KRW		Released
Forecast
Spread 		874
981
-10.95%		897
1 024
-12.4%		910
957
-4.88%
1 750


2 277


3 674

EBIT
Billions KRW		Released
Forecast
Spread 		647
751
-13.82%		651
836
-22.03%		492
569
-13.59%
1 446


1 955


3 379

Earnings before Tax (EBT)
Billions KRW		Released
Forecast
Spread 		626
799
-21.59%		671
834
-19.5%		576
569
1.22%
1 460


1 938


0,00

Net income
Billions KRW		Released
Forecast
Spread 		533
622
-14.21%		536
703
-23.81%		423
441
-4.08%
1 126


1 492


0,00

EPS
KRW		Released
Forecast
Spread 		3 671
4 103
-10.52%		3 574
4 619
-22.62%		2 045
1 937
5.59%
5 158


7 037


12 968

Announcement Date03/03/2329/02/2425/02/25-

Quarterly results

Fiscal PeriodDecember 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4
Net sales
Billions KRW		Released
Forecast
Spread 		524
606
-13.58%		672
646
4.09%		383
581
-34.19%		737
722
2.1%		875
804
8.84%		882
936
-5.75%		1 064
1 018
4.48%
993


1 080


1 168


1 279


1 192


1 353


1 467


1 521

EBITDA
Billions KRW		Released
Forecast
Spread








147
103
42.76%		205
198
3.28%		283
290
-2.24%		275
282
-2.47%
295


346


403


443













EBIT
Billions KRW		Released
Forecast
Spread 		183
193
-5.26%		268
224
19.62%		18,4
186
-90.07%		15,4
7,44
107.41%		72,5
77,0
-5.9%		208
213
-2.41%		196
270
-27.2%
252


312


364


443


396


493


538


611

Earnings before Tax (EBT)
Billions KRW		Released
Forecast
Spread 		190
180
5.68%		283
224
26.02%





104
82,6
26.15%		178
208
-14.47%		274
280
-2.13%
235






















Net income
Billions KRW		Released
Forecast
Spread 		148
156
-5.57%		222
174
27.63%		1,05
167
-99.37%		22,4
7,67
192.67%		78,0
63,8
22.24%		85,6
171
-49.99%		237
219
8.29%
205


243


260


279













EPS
KRW		Released
Forecast
Spread 		985
964
2.12%		1 487
1 045
42.29%





359
248
44.62%		394
823
-52.1%		1 146
928
23.47%























Announcement Date14/08/2307/11/2329/02/2409/05/2407/08/2408/11/2425/02/25--------

Upcoming sector events for Celltrion, Inc.

2025-03-24 ALPHAMAB ONCOLOGY: Q4 2024 Earnings Release
2025-03-25 ALVOTECH: Q4 2024 Earnings Release
2025-03-25 BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD.: Q4 2024 Earnings Release
2025-03-25 PHARMARON BEIJING CO., LTD.: Q4 2024 Earnings Release
2025-03-26 FORMYCON AG: Q4 2024 Earnings Release
2025-03-26 CENTESSA PHARMACEUTICALS PLC: Q4 2024 Earnings Release (Projected)
2025-03-26 HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2024 Earnings Release
2025-03-27 JOINN LABORATORIES(CHINA)CO.,LTD.: Q4 2024 Earnings Release
2025-03-27 R&G PHARMASTUDIES CO., LTD.: Q4 2024 Earnings Release
2025-04-16 EVOTEC SE: Q4 2024 Earnings Release
More events

Past sector events for Celltrion, Inc.

2025-03-20 HUMACYTE, INC.: Q4 2024 Earnings Release (Projected)
2025-03-20 07:00 am SIONNA THERAPEUTICS, INC.: Q4 2024 Earnings Release
2025-03-20 07:00 am ARS PHARMACEUTICALS, INC.: Q4 2024 Earnings Release
2025-03-20 02:00 am VALNEVA: Q4 2024 Earnings Release
2025-03-19 VORONOI, INC.: Q4 2024 Earnings Release
2025-03-19 VERA THERAPEUTICS, INC.: Q4 2024 Earnings Release (Projected)
2025-03-19 EXSCIENTIA PLC: Q4 2024 Earnings Release (Projected)
2025-03-17 04:15 pm GYRE THERAPEUTICS, INC.: Q4 2024 Earnings Release
2025-03-13 POLARIS GROUP: Q4 2024 Earnings Release
2025-03-11 AURA BIOSCIENCES, INC.: Q4 2024 Earnings Release (Projected)

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. A068270 Stock
  4. Calendar Celltrion, Inc.